Portland Global Advisors’s Idexx Laboratories IDXX Stock Holding History

Portland Global Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.79M	Sell	6,737 -1,410	-17%	-$904K	0.4%	46
2025 Q4	$5.51M	Buy	8,147 +6,224	+324%	+$4.24M	0.59%	42
2025 Q3	$1.23M	Buy	1,923 +8	+0.4%	+$4.86K	0.14%	67
2025 Q2	$1.03M	Buy	1,915 +52	+3%	+$24.9K	0.12%	70
2025 Q1	$782K	Buy	1,863 +7	+0.4%	+$3.04K	0.1%	73
2024 Q4	$767K	Sell	1,856 -1	-0.1%	-$439	0.1%	79
2024 Q3	$938K	Hold	1,857	–	–	0.12%	74
2024 Q2	$905K	Sell	1,857 -95	-5%	-$47.7K	0.12%	74
2024 Q1	$1.05M	Sell	1,952 -571	-23%	-$312K	0.14%	71
2023 Q4	$1.4M	Hold	2,523	–	–	0.21%	61
2023 Q3	$1.1M	Sell	2,523 -185	-7%	-$92.3K	0.18%	69
2023 Q2	$1.36M	Sell	2,708 -339	-11%	-$162K	0.22%	63
2023 Q1	$1.52M	Sell	3,047 -2	-0.1%	-$957	0.26%	63
2022 Q4	$1.24M	Hold	3,049	–	–	0.23%	69
2022 Q3	$993K	Buy	3,049 +12	+0.4%	+$4.41K	0.2%	72
2022 Q2	$1.06M	Hold	3,037	–	–	0.2%	70
2022 Q1	$1.66M	Sell	3,037 -183	-6%	-$96.3K	0.28%	62
2021 Q4	$2.12M	Buy	3,220 +193	+6%	+$121K	0.35%	51
2021 Q3	$1.88M	Buy	3,027 +3	+0.1%	+$2.02K	0.35%	55
2021 Q2	$1.91M	Sell	3,024 -135	-4%	-$74.5K	0.37%	52
2021 Q1	$1.55M	Buy	3,159 +375	+13%	+$188K	0.33%	55
2020 Q4	$1.39M	Buy	2,784 +10	+0.4%	+$4.47K	0.34%	53
2020 Q3	$1.09M	Hold	2,774	–	–	0.32%	52
2020 Q2	$916K	Hold	2,774	–	–	0.3%	54
2020 Q1	$672K	Sell	2,774 -150	-5%	-$39.1K	0.26%	57
2019 Q4	$764K	Sell	2,924 -420	-13%	-$111K	0.23%	61
2019 Q3	$909K	Hold	3,344	–	–	0.3%	49
2019 Q2	$921K	Buy	3,344 +400	+14%	+$98.6K	0.31%	48
2019 Q1	$658K	Hold	2,944	–	–	0.23%	55
2018 Q4	$548K	Sell	2,944 -670	-19%	-$137K	0.22%	58
2018 Q3	$902K	Buy	3,614 +124	+4%	+$30.1K	0.32%	48
2018 Q2	$761K	Buy	3,490 +50	+1%	+$10.3K	0.29%	51
2018 Q1	$658K	Sell	3,440 -250	-7%	-$46.1K	0.25%	57
2017 Q4	$577K	Hold	3,690	–	–	0.21%	60
2017 Q3	$574K	Hold	3,690	–	–	0.22%	62
2017 Q2	$596K	Hold	3,690	–	–	0.24%	60
2017 Q1	$571K	Hold	3,690	–	–	0.24%	60
2016 Q4	$433K	Sell	3,690 -230	-6%	-$26.2K	0.19%	66
2016 Q3	$442K	Hold	3,920	–	–	0.2%	69
2016 Q2	$364K	Hold	3,920	–	–	0.17%	74
2016 Q1	$307K	Hold	3,920	–	–	0.15%	79
2015 Q4	$286K	Hold	3,920	–	–	0.15%	85
2015 Q3	$291K	Hold	3,920	–	–	0.17%	79
2015 Q2	$251K	Buy	3,920 +1,120	+40%	+$77.5K	0.13%	92
2015 Q1	$216K	Hold	2,800	–	–	0.11%	104
2014 Q4	$208K	Buy	+2,800	New	+$196K	0.11%	111
2014 Q3	–	Sell	-3,200	Closed	-$214K	–	113
2014 Q2	$214K	Buy	+3,200	New	+$203K	0.11%	113

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Portland Global Advisors's IDXX Position: Q1 2026 in Review

Portland Global Advisors reduced its Idexx Laboratories (IDXX) stake by 17% in Q1 2026, selling an estimated $904K and leaving 6,737 shares worth $3.79M. The position accounts for 0.4% of the portfolio, ranked #46.

Portland Global Advisors first reported a position in IDXX in Q2 2014 and has held it in 47 quarters since. The position peaked at $5.51M in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Portland Global Advisors held 6,737 shares of Idexx Laboratories worth $3.79M as of Q1 2026.
Portland Global Advisors sold 1,410 Idexx Laboratories shares in Q1 2026, an estimated $904K.
Idexx Laboratories made up 0.4% of Portland Global Advisors's portfolio in Q1 2026, its #46 holding.
Portland Global Advisors first reported a position in Idexx Laboratories in Q2 2014 and has held it in 47 quarters since.
Portland Global Advisors's Idexx Laboratories position peaked at $5.51M in Q4 2025.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Portland Global Advisors's 13F filing for Q1 2026, filed 11 May 2026.